Trial intelligence / Profile preview

Hospital intensive monitoring study of adverse drug reactions for Kuai-Wei Tablet

ChiCTR-ONC-12002634Phase 4Completed

Sponsor
Institute of Basic Research in Clinical Medicine
Start
Nov 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of Kuaiwei Tablet, sponsored by Institute of Basic Research in Clinical Medicine. Primary endpoint: Incidence of severe adverse drug reactions. Started Nov 2012; status: completed.

02

Drugs

Kuaiwei Tablet

Beyond the preview

Go deeper on ChiCTR-ONC-12002634.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-ONC-12002634.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call